Clinical Trial 49952

Evergreen Park, IL 60805


Summary:

Osimertinib stopped responding or did not respond to treatment? Try the SAFFRON study! This may be the research study for you.

We encourage all participants to consult their medical team before participating in research studies.

Criteria:

If you have locally advanced or metastatic NSCLC, tested positive for EGFR and MET, and your Osimertinib treatment stopped responding, you may qualify for this study.


Qualified Participants May Receive:

Compensation and transportation are available.


Available At:

GenHarp Clinical Solutions
9730 S. Western Ave., Suite 218
Evergreen Park, IL 60805
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'
OctoberAwareness

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.